A Review on the Clinical Utility of PSA in Cancer Prostate
Open Access
- 3 March 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Indian Journal of Surgical Oncology
- Vol. 3 (2), 120-129
- https://doi.org/10.1007/s13193-012-0142-6
Abstract
Prostate cancer has come to share the oncological centrestage among male cancers. The availability of Serum Prostate Specific Antigen, PSA, as a marker has encouraged it’s use to diagnose both cancer and cancer recurrence. Some clarity is required about its precise role in clinical practice. The available literature on Prostate Specific Antigen was reviewed; Articles were reviewed for content, applicability to the problem at hand, availability of data about sensitivity and specificity of values, refinements in measurements and finally for impact of screening programmes using these values on survival and quality of life. The data in the literature was critically re-evaluated and analysed to draw reasonable conclusions. Serum PSA measurements show variable reliability when it comes to diagnosis of Prostate cancer, given the dynamics of PSA physiology. Surrogate measures like PSA density, PSA velocity, free-to-complexed PSA ratio, percentage Pro-PSA, etc., have been used to improve the predictive utility of this assay for Prostate cancer. The ability of PSA to detect those cancers that will cost life, and thereby permit early curative treatment, is as yet unclear. It’s most definitive role appears to be in diagnosing recurrences after adequate surgical treatment, and in evaluating response to treatment.Keywords
This publication has 95 references indexed in Scilit:
- The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE StudyJournal of Urology, 2011
- Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination SurveyJournal of Clinical Oncology, 2010
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer AggressivenessCancer Epidemiology, Biomarkers & Prevention, 2010
- Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004Cancer Causes & Control, 2010
- Prostate‐specific antigen ‘bounce’ after permanent 125I‐implant brachytherapy in Japanese men: a multi‐institutional pooled analysisBJU International, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyThe New England Journal of Medicine, 2009
- Body Composition and Serum Prostate-Specific Antigen: Review and Findings from Flint Men’s Health StudyUrology, 2008
- Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian populationIndian Journal of Urology, 2007
- Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of CurabilityJNCI Journal of the National Cancer Institute, 2006
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateThe New England Journal of Medicine, 1987